Forfivo
- Product NDC
- 52427-575
- 11-digit product format
- 524270575
- Labeler code
- 52427
- Product ID
- 52427-575_0b5f98f8-e57d-3636-bb45-78a1e564f6fc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- bupropion hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Almatica Pharma Inc.
- Application
- NDA022497
- Marketing category
- NDA
- Marketing start
- 2017-05-15
- Marketing end
- 0000-00-00
- Substance
- BUPROPION HYDROCHLORIDE
- Active strength
- 450 mg/1
- Pharmacologic classes
- Aminoketone [EPC], Dopamine Uptake Inhibitors [MoA], Increased Dopamine Activity [PE], Increased Norepinephrine Activity [PE], Norepinephrine Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 52427-575 | D | Discontinued by firm | 2026-08-03 | ||
| excluded package | package | 52427-575 | 52427-575-30 | D | Discontinued by firm | 2026-08-03 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 52427-575-30 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 52427-575-30 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 52427-575-30 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 52427-575-30 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 52427-575-30 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 52427-575-30 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 52427-575-30 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 52427-575-30 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 52427-575-30 | 0efc9e666f02… | f202fb6c5f17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022497-001 | FORFIVO XL | BUPROPION HYDROCHLORIDE | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N022497-001 | 7674479 | 2028-08-23 | Drug product | 2011-11-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD | 2011-11-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022497-001 | FORFIVO XL | 450MG | TABLET, EXTENDED RELEASE / ORAL | RLD, RS | 2011-11-10 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N022497-001 | 7674479 | 2028-08-23 | Drug product | 2011-11-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N022497-001 | 7674479 | 2028-08-23 | Drug product | 2011-11-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N022497-001 | 7674479 | 2028-08-23 | Drug product | 2011-11-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N022497-001 | 7674479 | 2027-06-25 | Drug product | 2011-11-28 | cb3db0bc1861… |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 52427-575-30 | EA - Each | 52427-575 | c2e548f1-1b02-46a8-aabe-56d018832910 | 1 | 2017-08-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BUPROPION HCl ER (XL) | BUPROPION HCL ER | Lifestar Pharma LLC | df959e1b-3f6d-42cf-8521-fe03b5a4ceb8 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | 022497 NDA022497 |
| Forfivo XL | BUPROPION HYDROCHLORIDE | Upsher-Smith Laboratories, LLC | 80b01182-dc94-4990-8ebb-55c306d7e536 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | 022497 NDA022497 |
| bupropion hydrochloride | BUPROPION HYDROCHLORIDE | Upsher-Smith Laboratories, LLC | 98d5977f-9b32-46db-bd36-a2c4d1b0710a | 2025-08-29 | Boxed warning, Warnings, Adverse reactions | 022497 NDA022497 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 52427-575-30 | 52427057530 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (52427-575-30) | 2017-05-15 | 0000-00-00 | No | No | Current |